Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Exercise of Options and Director Dealing

6 Dec 2018 07:00

RNS Number : 5599J
Surface Transforms PLC
06 December 2018
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Surface Transforms plc

 

("Surface Transforms" or the "Company")

 

Exercise of Options and Director Dealing

 

Surface Transforms plc (AIM: SCE) announces that the Company was notified on 5 December 2018 that Dr Kevin Johnson (CEO of Surface Transforms Plc) exercised options over 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares").

 

Specifically, on 5 December 2018, Dr Kevin Johnson purchased 345,000 Ordinary Shares at a price of 9p per Ordinary Share and purchased 330,000 Ordinary Shares at a price of 11.5p.

 

Following the above transactions, Dr Johnson will be beneficially interested in 799,000 Ordinary Shares, which equates to approximately 0.6 per cent. of the Company's total issued share capital.

 

Dr Johnson has advised that he intends to transfer all of these shares to his SIPP but this will not change his beneficial interest in the Company.

 

Admission and Total Voting Rights

 

The new Ordinary Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares of the Company. Application will be made for the 675,000 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence at 8.00 a.m. on 11 December 2018. Following Admission, the total number of voting rights in the Company will be 123,710,416 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

- Ends -

 

 

 

For enquiries, please contact:

Surface Transforms plc

 

 

Kevin Johnson, CEO

Michael Cunningham CFO

 

+44 151 356 2141

+44 151 348 8882

David Bundred, Chairman

+44 7785 388 848

 

Cantor Fitzgerald Europe (Nomad & Joint-Broker)

+44 20 7894 7000

David Foreman, Richard Salmond, Michael Boot (Corporate Finance)

Caspar Shand Kydd, Gregor Paterson (Sales)

 

 

 

FinnCap Ltd (Joint-Broker)

+44 20 7220 0500

Richard Chambers (Corporate Broking)

Ed Frisby / Giles Rolls (Corporate Finance)

 

 

 

For further Company details, visit www.surfacetransforms.com.

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.

 

 

 

 

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMR") and persons closely associated with them ("PCA")

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Dr Kevin Johnson

2

Reason for notification

 

 

 

a.

Position/Status

PDMR

CEO

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Surface Transforms plc

b.

LEI

213800GQHNJPE5O8XO79

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 1p each 

ISIN: GB0002892528

b.

Nature of the transaction

Purchase of 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares).

 

c.

Price(s) and volume(s)

- Transaction 1 (Purchase)

 

- Transaction 2

(purchase)

 

Price(s)

Volume(s)

9.00p

345,000

11.5p

330,000

 

d.

Aggregated information

- Transaction 1

(purchase)

 

- Transaction 2

(purchase)

Price(s)

Aggregated volume(s)

Aggregated Total

9p

345,000

£31,050.00

11.5p

330,000

£37,950.00

 

e.

Date of the transaction

5/12/2018

f.

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGGPCPUPRGWA
Date   Source Headline
2nd Jan 20255:57 pmRNSHolding(s) in Company
10th Dec 20243:16 pmRNSHolding(s) in Company
4th Dec 202411:18 amRNSHolding(s) in Company
3rd Dec 202412:20 pmRNSHolding(s) in Company
8th Nov 20247:00 amRNSHolding(s) in Company
6th Nov 20245:15 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSDirectorate Change
1st Oct 20243:37 pmRNSNotification of Major Holdings
30th Sep 20247:00 amRNSInterim results - 6 months ended 30 June 2024
16th Sep 20247:00 amRNSAppointment of new non-executive chair
15th Aug 20247:00 amRNSAward of 2024 LTIP share options
25th Jul 20244:22 pmRNSNotification of Major Holdings
23rd Jul 20243:40 pmRNSResult of Annual General Meeting
23rd Jul 20247:00 amRNSAGM Statement
28th Jun 20247:00 amRNSYear end results and Notice of AGM
18th Jun 20247:00 amRNSFY23 Audit Update
11th Jun 20245:00 pmRNSNotification of Major Holdings
31st May 202411:36 amRNSNotification of Major Holdings
31st May 202411:34 amRNSNotification of Major Holdings
31st May 202411:31 amRNSNotification of Major Holdings
28th May 20247:01 amRNSNotification of Major Holdings
28th May 20247:00 amRNSTotal Voting Rights
24th May 20245:30 pmRNSNotification of Major Holdings
24th May 20247:00 amRNSResult of Open Offer
23rd May 202412:15 pmRNSResult of General Meeting and Total Voting Rights
14th May 20241:49 pmEQSHardman Talks Video | Surface Transforms (SCE): Placing
9th May 202410:38 amEQSHardman & Co Research on Surface Transforms (SCE): Open Offer
8th May 20245:18 pmRNSNotification of Major Holdings
8th May 20244:01 pmRNSReminder of Shareholder Presentation
8th May 202411:17 amRNSNotification of Major Holdings
3rd May 202412:16 pmRNSHolding(s) in Company
2nd May 202412:23 pmRNSReplacement: Result of Placing & Open Offer Launch
2nd May 20249:33 amRNSResult of Placing, Open Offer Launch & GM Notice
1st May 20245:30 pmRNSProposed Placing, Subscription and Open Offer
17th Apr 20248:16 amRNS2024 Sales Outlook
15th Apr 20247:00 amRNSHolding(s) in Company
9th Apr 20247:00 amRNSQ1 2024 sales and operations update
16th Jan 20247:00 amRNSPDMR Dealing - Award of LTIP share options
8th Jan 20247:00 amRNSPre-Close Trading and Operational Update
20th Dec 20232:50 pmRNSNotification of Major Holdings
19th Dec 20239:37 amRNSHolding(s) in Company
19th Dec 20239:31 amRNSHolding(s) in Company
18th Dec 202312:24 pmRNSResult of General Meeting and Total Voting Rights
11th Dec 202311:34 amRNSConclusion of £13.2m Loan agreement
11th Dec 20237:00 amRNSResult of Open Offer
29th Nov 202311:06 amEQSHardman & Co Video | Surface Transforms (SCE) Open Offer and Q&A
22nd Nov 20237:30 amEQSHardman & Co Research on Surface Transforms (SCE): Funding for growth: Open Offer
21st Nov 20233:25 pmRNSNotification of Major Holdings
21st Nov 20237:00 amRNSReminder of Shareholder Presentation
14th Nov 20238:12 amRNSResult of Placing, Open Offer Launch & GM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.